Showing results (511-520 of 734) with videos related to
Sort By:
Pageof 74
Transplantation and Cellular Therapy|July 12, 2024
Autologous Stem Cell Transplant in Fit Patients With Late Relapsed Diffuse Large B-Cell Lymphoma That Responded to Salvage ChemotherapyAung M Tun, Yucai Wang, Seth Maliske, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2005
Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation for patients with primary systemic amyloidosisLuis F Porrata, Morie A Gertz, Mark R Litzow, et al.Leukemia & Lymphoma|May 4, 2012
Absolute monocyte/lymphocyte count prognostic score is independent of immunohistochemically determined cell of origin in predicting survival in diffuse large B-cell lymphomaLuis F Porrata, Kay Ristow, Thomas M Habermann, et al.British Journal of Haematology|April 21, 2026
Lymphocyte dynamics after CAR-T therapy for non-Hodgkin lymphomaSarah Dingli, Paul Rothweiler, Andre De Menezes Silva Corraes, et al.Journal of Hematology & Oncology|March 29, 2022
Metabolic characteristics and prognostic differentiation of aggressive lymphoma using one-month post-CAR-T FDG PET/CTWilliam G Breen, Matthew A Hathcock, Jason R Young, et al.Blood Advances|February 18, 2025
Comparison of outcomes in postinduction strategies for primary central nervous system lymphoma: a Mayo Clinic experienceSteven R Hwang, Richard C Godby, Brianna J Negaard, et al.Journal of the National Cancer Institute. Monographs|September 1, 2014
Medical history, lifestyle, family history, and occupational risk factors for peripheral T-cell lymphomas: the InterLymph Non-Hodgkin Lymphoma Subtypes ProjectSophia S Wang, Christopher R Flowers, Marshall E Kadin, et al.British Journal of Haematology|August 7, 2018
Targeting CD38 with daratumumab is lethal to Waldenström macroglobulinaemia cellsAneel Paulus, Alak Manna, Sharoon Akhtar, et al.Blood|April 29, 2018
Brentuximab vedotin plus bendamustine: a highly active first salvage regimen for relapsed or refractory Hodgkin lymphomaAnn S LaCasce, R Gregory Bociek, Ahmed Sawas, et al.American Journal of Hematology|June 22, 2012
Germline variation in complement genes and event-free survival in follicular and diffuse large B-cell lymphomaBridget Charbonneau, Matthew J Maurer, Zachary S Fredericksen, et al.Pageof 74